| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/28/2004 | CN1159339C Rice glutashion phospholipid hydrogen peroxidas gene, protein and their application |
| 07/28/2004 | CN1159333C Trichina antigen gene Ts 87 and use thereof |
| 07/27/2004 | US6768044 Chimeric hydroxyl-phenyl pyruvate dioxygenase, DNA sequence and method for obtaining plants containing such a gene, with herbicide tolerance |
| 07/27/2004 | US6768043 Das5, a P450 protein involved in the brassinosteroid biosynthesis pathway in plants |
| 07/27/2004 | US6768042 Selective control of lignin biosynthesis in transgenic plants |
| 07/27/2004 | US6768041 Polynucleotides that encode polypeptides involved in plant cell signaling are provided, together with genetic constructs comprising such polynucleotides |
| 07/27/2004 | US6768004 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1F7, an anti-idiotypic antibody reactive with anti-HIV antibodies |
| 07/27/2004 | US6768003 Screening a substance for the ability of the substance to modify, transcriptional activator protein function, and a method for isolating other transcriptional activator protein molecules |
| 07/27/2004 | US6768001 Xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme |
| 07/27/2004 | US6767997 Antibodies that bind deoxyribonuclease IIβ enzyme proteins |
| 07/27/2004 | US6767996 Altered antibodies and their preparation |
| 07/27/2004 | US6767995 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | US6767887 Peptides that stimulate release of insulin; treating diabetes |
| 07/27/2004 | US6767879 Detergents comprising cellulases |
| 07/27/2004 | US6767748 Apparatus for detection and analysis of dna on microarrays |
| 07/27/2004 | US6767744 Isolated from a methylomonas sp encoding enzymes in the carbon flux pathway; useful in c1 metabolizing microorganisms for the manipulation of the carbon flux pathway |
| 07/27/2004 | US6767743 Method and an apparatus for generating shockwave, a method and an apparatus for accelerating particles, an apparatus for delivering drugs, and a method and an apparatus for delivering DNA |
| 07/27/2004 | US6767742 Antibody-mediated down-regulation of plant proteins |
| 07/27/2004 | US6767739 For therapy of atherosclerosis, cardiovascular disease, abnormal cholesterol metabolism, abnormal lipid metabolism |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767735 Introduction of a desired gene, and a plant hormone signal transduction gene as a selectable marker gene |
| 07/27/2004 | US6767727 For treatment of genetic disorders; targets for competitive binding assays; drug screening |
| 07/27/2004 | US6767724 Replicating nucleotide sequences using moloney murine leukemia virus polymerase; forensics; medical diagnosis |
| 07/27/2004 | US6767723 Method for synthesis of nucleic acids |
| 07/27/2004 | US6767722 Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 |
| 07/27/2004 | US6767719 Mouse telomerase reverse transcriptase |
| 07/27/2004 | US6767712 Models of prion disease |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767706 Integrated active flux microfluidic devices and methods |
| 07/27/2004 | US6767705 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767703 Materials and methods for identifying and analyzing intermediate tandem repeat DNA markers |
| 07/27/2004 | US6767702 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 07/27/2004 | US6767701 By use of an episomal replicating autonomous mantainance in aspergillus (ama) 1-based plasmid vector, thus achieving a high frequency of transformation and a stable and standard uniformly high level of gene expression |
| 07/27/2004 | US6767700 Tumor cells having tumorigenic potential but lacking invasive/metastatic potential, method for preparing them and screening method for metastasis-related genes using the same |
| 07/27/2004 | US6767699 Viral purification; mix viral preparation and ion exchange resins, remove unbound viral particles, elute bound viral particles, recover preferential replicon |
| 07/27/2004 | US6767545 Composition for use in treating or preventing infection by pseudomonas aeruginosa comprising a p. aeruginosa pilin protein having an n-terminal peptide region modified to prevent self assembly of the peptide |
| 07/27/2004 | US6767512 Achieving desired gradient profile faster and accurately |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/22/2004 | WO2004061408A2 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 07/22/2004 | WO2004061128A1 Selection procedure for identifying transgenic cells, embryos, and plants without the use of antibiotics |
| 07/22/2004 | WO2004061122A2 Cell proliferation-related polypeptides and uses therefor |
| 07/22/2004 | WO2004061119A2 Rolling circle amplification of rna |
| 07/22/2004 | WO2004061118A2 Compositions and methods for nucleic acid extraction from biological samples |
| 07/22/2004 | WO2004061113A1 Adeno-associated virus mediated b7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers |
| 07/22/2004 | WO2004061112A2 Method of identifying organisms having a mutated signal transduction pathway |
| 07/22/2004 | WO2004061111A1 Dna array for high throughput solid-phase transfection and method for producing the same |
| 07/22/2004 | WO2004061110A1 Complementation method for producing rna-containing virus-like particles of hepatotropic viruses |
| 07/22/2004 | WO2004061109A1 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 07/22/2004 | WO2004061108A1 Adiponectin receptor and gene coding for the same |
| 07/22/2004 | WO2004061107A1 Cell growth inhibitor using sphingosine kinase 2, method of constructing fused protein having its nuclear localization signal, method of screening drug candidate, and screening kit |
| 07/22/2004 | WO2004061106A1 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same |
| 07/22/2004 | WO2004061105A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof |
| 07/22/2004 | WO2004061099A1 Method for treating an early embryo by creatin a chimera |
| 07/22/2004 | WO2004061098A1 Manipulation of ascorbic acid levels in plants |
| 07/22/2004 | WO2004061097A2 Crystal structure of glutamate racemase (muri) |
| 07/22/2004 | WO2004061096A1 Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders |
| 07/22/2004 | WO2004061095A2 Micro-organism strains having an inactive phor/phon operon for carrying out a method for the overproduction of metabolites, in particular exhibiting an antibiotic and enzymatic activity |
| 07/22/2004 | WO2004061087A2 Methods and compositions of ecdysozoan molt inhibition |
| 07/22/2004 | WO2004061083A2 Rna interference |
| 07/22/2004 | WO2004061081A2 Sirna compounds and methods for the downregulation of gene expression |
| 07/22/2004 | WO2004061080A2 Stress-related polypeptides and uses therefor |
| 07/22/2004 | WO2004061078A2 Method to identify and analyze genes having modified expression in activated cells with secretory lysosomes |
| 07/22/2004 | WO2004061077A2 Increasing gamete production with a gene switch |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060918A1 Detecting lipocalin |
| 07/22/2004 | WO2004060912A2 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes |
| 07/22/2004 | WO2004060909A2 Increasing production of proteins in gram-positive microorganisms |
| 07/22/2004 | WO2004060869A2 Methods and compositions for catalytic dna exchange in a sequence manner |
| 07/22/2004 | WO2004060476A2 Wound healing method and kits |
| 07/22/2004 | WO2004060408A1 p53 TREATMENT OF PAPILLOMAVIRUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS |
| 07/22/2004 | WO2004060407A1 Calcium phosphate ceramics and particles for in vivo and in vitro transfection |
| 07/22/2004 | WO2004060392A1 Lactoferrin protein with iron for treating iron deficiency and anemia |
| 07/22/2004 | WO2004060390A2 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 07/22/2004 | WO2004060350A1 Immobilisation of dna-labelled lipid vesicles on dna arrays |
| 07/22/2004 | WO2004060323A2 Novel inhibitors of poxvirus replication |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | WO2004060277A2 Process for purification of plasmid dna |
| 07/22/2004 | WO2004060274A2 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells |
| 07/22/2004 | WO2004060270A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/22/2004 | WO2004060269A2 Mda-7 and free radicals in the treatment of cancer |
| 07/22/2004 | WO2004060056A2 Sperm-induced cellular activation |
| 07/22/2004 | WO2004060055A1 Wt1 transgenic animal |
| 07/22/2004 | WO2004060053A2 Transgenic mice expressing human cd20 |
| 07/22/2004 | WO2004060052A2 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | WO2004050844A3 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 07/22/2004 | WO2004050695A3 Expression of polypeptides in filamentous fungi |
| 07/22/2004 | WO2004048558A3 Heparanase mediated cell adhesion and uses thereof |
| 07/22/2004 | WO2004045513A3 Coronary artery disease treatment |
| 07/22/2004 | WO2004043395A9 Methods and compositions for treating neurological disorders |
| 07/22/2004 | WO2004039983A3 Method for inserting a nucleic acid of interest into a prokaryotic or eukaryotic cell by homologous recombination |
| 07/22/2004 | WO2004039978A3 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/22/2004 | WO2004037861A3 Neutralizing antibodies against gdf-8 and uses therefor |
| 07/22/2004 | WO2004035789A9 Gene families associated with cancers |
| 07/22/2004 | WO2004033718A3 Trap-tagging: a novel method for the identification and purification of rna-protein complexes |
| 07/22/2004 | WO2004033498A3 .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof |
| 07/22/2004 | WO2004033417A3 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |